Related Experiment Video
Updated: Aug 23, 2026
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques
Dennis M Klinman1, Hang Xie, Stephen F Little
1Section of Retroviral Immunology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bldg. 29A, Rm. 3 D 10, Bethesda, MD 20892, USA. klinman@cber.fda.gov
Abstract:
Synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs act as immune adjuvants, improving the immune response elicited by co-administered vaccines. Combining CpG ODN with anthrax vaccine adsorbed (AVA, the licensed human vaccine) increased the speed, magnitude and avidity of the resultant anti-anthrax response. The protective activity of these Abs was established by passive transfer to anthrax-challenged mice. The ability of CpG ODN to accelerate and magnify the immune response to AVA suggests this strategy may contribute to the development of prophylactic and therapeutic vaccines against biothreat pathogens.
